Document Detail


Comparison of immunogenicities of recombinant Plasmodium vivax merozoite surface protein 1 19- and 42-kiloDalton fragments expressed in Escherichia coli.
MedLine Citation:
PMID:  15385477     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The 42- and 19-kDa C-terminal fragments of merozoite surface protein 1 (MSP-1(42) and MSP-1(19), respectively) are both promising blood-stage vaccine candidate antigens. At present, it is not clear which of the two antigens will be more suitable for inclusion in a cocktail malaria vaccine. In the present study, we expressed the two C-terminal fragments of Plasmodium vivax MSP-1 (PvMSP-1) in an Escherichia coli expression system and purified them by using a rapid two-step protocol. Both of the products were recognized by monoclonal antibodies against PvMSP-1 as well as by immune sera from several individuals exposed to P. vivax. We analyzed and compared the immunological responses to recombinant PvMSP-1(19) and PvMSP-1(42) in mice by using six different adjuvant formulations. Moderate to high antibody responses were observed with both of the antigens in different adjuvant formulations. Surprisingly, alum, which is generally considered to be a poor adjuvant for recombinant malaria antigens, was found to be as good an adjuvant as Montanide ISA 720, ASO2A, and other adjuvant formulations. Most adjuvant formulations induced high levels of immunoglobulin G1 (IgG1), followed by IgG3 and IgG2. Lymphocytes from animals in the PvMSP-1(42)- and PvMSP-1(19)-immunized groups showed proliferative responses upon stimulation with the respective antigens, and high levels of interleukin-4 (IL-4), IL-5, and gamma interferon were detected in the culture supernatants. Immunodepletion studies with sera from mice immunized with these two antigens showed that while immunization with PvMSP-1(42) does produce a PvMSP-1(19)-specific response, a substantial portion is also focused on structures in PvMSP-1(42) not represented by the epidermal growth factor-like domains of PvMSP-1(19). These findings may have implications for the design of MSP-1-based vaccine constructs.
Authors:
Suraksha Sachdeva; Gul Ahmad; Pawan Malhotra; Paushali Mukherjee; V S Chauhan
Related Documents :
10548307 - Interethnic differences in the humoral response to non-repetitive regions of the plasmo...
6199717 - A high molecular weight antigen in plasmodium falciparum recognized by inhibitory monoc...
17095277 - Characterization of anti-var2csa-pfemp1 cytoadhesion inhibitory mouse monoclonal antibo...
2082157 - Reduced antibody response to the repetitive sequence of the plasmodium falciparum circu...
19868177 - Studies in glomerulonephritis : iii. an attempt to produce glomerulonephritis by repeat...
18287027 - Antisera induced by infusions of autologous ad-cd154-leukemia b cells identify ror1 as ...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Infection and immunity     Volume:  72     ISSN:  0019-9567     ISO Abbreviation:  Infect. Immun.     Publication Date:  2004 Oct 
Date Detail:
Created Date:  2004-09-23     Completed Date:  2004-10-25     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  0246127     Medline TA:  Infect Immun     Country:  United States    
Other Details:
Languages:  eng     Pagination:  5775-82     Citation Subset:  IM    
Affiliation:
International Centre for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi 110067, India. virander@icgeb.res.in
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adjuvants, Immunologic
Animals
Antibodies, Protozoan / analysis,  immunology
Enzyme-Linked Immunosorbent Assay
Epitopes / immunology
Escherichia coli / genetics*
Humans
Immunoglobulin G / analysis,  immunology
Immunoglobulin Isotypes / analysis,  immunology
Malaria Vaccines / immunology
Malaria, Vivax / immunology
Merozoite Surface Protein 1 / chemistry*,  genetics,  immunology*,  isolation & purification
Mice
Mice, Inbred BALB C
Molecular Weight
Peptide Fragments / chemistry*,  genetics,  immunology*,  isolation & purification
Plasmodium vivax / immunology*
Recombinant Proteins / chemistry,  genetics,  immunology,  isolation & purification
Chemical
Reg. No./Substance:
0/Adjuvants, Immunologic; 0/Antibodies, Protozoan; 0/Epitopes; 0/Immunoglobulin G; 0/Immunoglobulin Isotypes; 0/Malaria Vaccines; 0/Merozoite Surface Protein 1; 0/Peptide Fragments; 0/Recombinant Proteins
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  CD28 costimulation is required for the expression of T-cell-dependent cell-mediated immunity against...
Next Document:  The Ton system, an ABC transporter, and a universally conserved GTPase are involved in iron utilizat...